{"id":"W4385707295","doi":"10.1097/01.hs9.0000970420.62475.d0","title":"P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Multiple myeloma; Daratumumab; Cytokine release syndrome; Oncology; Bortezomib; Refractory (planetary science); Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Chimeric antigen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381176,0.0002714296,0.0008852687,0.0003096829,0.0005945915,0.000957986,0.0004426485,0.0006742596,0.00191081],"category_scores_gemma":[0.001349585,0.0001908053,0.001072674,0.0004630724,0.0002381783,0.000723254,0.0006757002,0.001416979,0.0005233311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009369556,"about_ca_system_score_gemma":0.0008068998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001591666,"about_ca_topic_score_gemma":0.002924607,"domain_scores_codex":[0.9995796,0.0001027168,0.00004662959,0.000102432,0.00006246707,0.0001061678],"domain_scores_gemma":[0.998941,0.0001651045,0.0002858837,0.00009463294,0.0001173076,0.0003960299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1809054,0.004855456,0.5215905,0.001006755,0.003598852,0.00339169,0.0008530457,0.001899803,0.008117063,0.0003061125,0.0203313,0.2531441],"study_design_scores_gemma":[0.01573175,0.07060373,0.8800316,0.000389782,0.003509937,0.002753292,0.0003284324,0.001693367,0.00228039,0.0004414149,0.02216004,0.0000761566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892764,0.00438969,0.0003485844,0.0005580942,0.000100086,0.0002040859,0.002926739,0.00003620429,0.002160135],"genre_scores_gemma":[0.990001,0.001020502,0.0002911062,0.0009169909,0.0001350602,0.0001871747,0.006184685,0.00001135421,0.001252184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00191081,"threshold_uncertainty_score":0.00730443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01996740738613229,"score_gpt":0.2765928248278406,"score_spread":0.2566254174417083,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}